Pedro Veliça

1.9k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

Pedro Veliça is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Pedro Veliça has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Pedro Veliça's work include Immune Cell Function and Interaction (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and CAR-T cell therapy research (6 papers). Pedro Veliça is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and CAR-T cell therapy research (6 papers). Pedro Veliça collaborates with scholars based in United Kingdom, Sweden and United States. Pedro Veliça's co-authors include Randall S. Johnson, Christopher M. Bunce, Helene Rundqvist, Ananda W. Goldrath, David Macías, Petros A. Tyrakis, Anthony T. Phan, Asís Palazón, David Bargiela and John Lövrot and has published in prestigious journals such as Nature, The Journal of Immunology and Cancer Cell.

In The Last Decade

Pedro Veliça

23 papers receiving 1.3k citations

Hit Papers

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumo... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
    2017 408 citations Asís Palazón, Petros A. Tyrakis et al. Cancer Cell profile →

Peers

Pedro Veliça
Chen‐Ming Su Taiwan
Anna Rita Cantelmo Italy
Zheng Gong China
Susana Constantino Rosa Santos Portugal
Hui Shi China
Esther Castaño Spain
Fabien Franco Switzerland
Jeremy A. Meier United States
Tae-Hee Lee South Korea
Rosa Martín‐Pérez Belgium
Chen‐Ming Su Taiwan
Pedro Veliça
Citations per year, relative to Pedro Veliça Pedro Veliça (= 1×) peers Chen‐Ming Su

Countries citing papers authored by Pedro Veliça

Since Specialization
Citations

This map shows the geographic impact of Pedro Veliça's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Veliça with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Veliça more than expected).

Fields of papers citing papers by Pedro Veliça

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Veliça. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Veliça. The network helps show where Pedro Veliça may publish in the future.

Co-authorship network of co-authors of Pedro Veliça

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Veliça. A scholar is included among the top collaborators of Pedro Veliça based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Veliça. Pedro Veliça is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bargiela, David, Pedro P. Cunha, Pedro Veliça, et al.. (2024). The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy. Frontiers in Immunology. 15. 1293723–1293723. 1 indexed citations
2.
Cunha, Pedro P., David Bargiela, Brennan J. Wadsworth, et al.. (2023). Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy. eLife. 12. 33 indexed citations
3.
Barbieri, Laura, Pedro Veliça, Paulo A. Gameiro, et al.. (2023). Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells. Frontiers in Immunology. 14. 1101433–1101433. 32 indexed citations
4.
Cunha, Pedro P., Brennan J. Wadsworth, Guinevere L. Grice, et al.. (2023). Glutarate regulates T cell metabolism and anti-tumour immunity. Nature Metabolism. 5(10). 1747–1764. 36 indexed citations
5.
Cunha, Pedro P., David Bargiela, Laura Barbieri, et al.. (2022). Infiltration of Tumors Is Regulated by T cell–Intrinsic Nitric Oxide Synthesis. Cancer Immunology Research. 11(3). 351–363. 4 indexed citations
6.
Bargiela, David, Pedro P. Cunha, Pedro Veliça, et al.. (2022). Vitamin B6 Metabolism Determines T Cell Anti-Tumor Responses. Frontiers in Immunology. 13. 23 indexed citations
7.
Gojković, Miloš, Pedro P. Cunha, Laura Barbieri, et al.. (2021). Oxygen-Mediated Suppression of CD8+ T Cell Proliferation by Macrophages: Role of Pharmacological Inhibitors of HIF Degradation. Frontiers in Immunology. 12. 633586–633586. 13 indexed citations
8.
Veliça, Pedro, Pedro P. Cunha, Iosifina P. Foskolou, et al.. (2021). Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy. Cancer Immunology Research. 9(4). 401–414. 38 indexed citations
9.
Foskolou, Iosifina P., Laura Barbieri, David Bargiela, et al.. (2020). The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome. Blood Advances. 4(18). 4483–4493. 26 indexed citations
10.
Gojković, Miloš, et al.. (2020). Deregulated hypoxic response in myeloid cells: A model for high‐altitude pulmonary oedema (HAPE). Acta Physiologica. 229(2). e13461–e13461. 7 indexed citations
11.
Rundqvist, Helene, Pedro Veliça, Laura Barbieri, et al.. (2020). Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. eLife. 9. 129 indexed citations
12.
Palazón, Asís, Petros A. Tyrakis, David Macías, et al.. (2017). An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression. Cancer Cell. 32(5). 669–683.e5. 408 indexed citations breakdown →
13.
Holler, Angelika, Sara Ghorashian, Alastair Hotblack, et al.. (2016). Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy. Haematologica. 101(4). 482–490. 2 indexed citations
14.
Tyrakis, Petros A., Asís Palazón, David Macías, et al.. (2016). S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature. 540(7632). 236–241. 326 indexed citations
15.
Veliça, Pedro, Siân M. Henson, Angelika Holler, et al.. (2015). Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation. Cancer Research. 75(13). 2641–2652. 19 indexed citations
16.
Khanim, Farhat L., Nicholas Davies, Pedro Veliça, et al.. (2014). Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. British Journal of Cancer. 110(6). 1506–1516. 27 indexed citations
17.
Veliça, Pedro & Christopher M. Bunce. (2011). A quick, simple and unbiased method to quantify C2C12 myogenic differentiation. Muscle & Nerve. 44(3). 366–370. 78 indexed citations
18.
Veliça, Pedro, Farhat L. Khanim, & Christopher M. Bunce. (2010). Prostaglandin D2 inhibits C2C12 myogenesis. Molecular and Cellular Endocrinology. 319(1-2). 71–78. 20 indexed citations
19.
Veliça, Pedro, Nicholas Davies, Pedro P. Rocha, et al.. (2009). Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers. Molecular Cancer. 8(1). 121–121. 63 indexed citations
20.
Veliça, Pedro & Christopher M. Bunce. (2008). Prostaglandins in muscle regeneration. Journal of Muscle Research and Cell Motility. 29(6-8). 163–167. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chen‐Ming Su Breakdown of academic impact, for papers by Anna Rita Cantelmo Breakdown of academic impact, for papers by Zheng Gong Breakdown of academic impact, for papers by Susana Constantino Rosa Santos Breakdown of academic impact, for papers by Hui Shi Breakdown of academic impact, for papers by Esther Castaño Breakdown of academic impact, for papers by Fabien Franco Breakdown of academic impact, for papers by Jeremy A. Meier Breakdown of academic impact, for papers by Tae-Hee Lee Breakdown of academic impact, for papers by Rosa Martín‐Pérez
Rankless by CCL
2026